Apitope raises $13.5 mln
Apitope said Tuesday it raised 12 million euros (US$13.5 million) in Series B financing led by new investor Wales Life Sciences Fund. Current investors Vesalius Biocapital, LRM, PMV and Wyvern also participated in the round. Cardiff, England-based Apitope is a drug discovery and development company.
29 September 2015•5 mins read
